Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer reports regulatory and pipeline highlights of first quarter 2018

May 10, 2018

First subjects dosed in first-in-human study of TransCon CNP

May 10, 2018

Japan AMED selects FunPep project for orphan drug support program

May 10, 2018

BDII-selective inhibitor ABBV-744 active against acute myelogenous leukemia, prostate cancer

May 9, 2018

OncoSec Medical and Merck & Co. to collaborate on clinical trial

May 9, 2018

XtalPi and Pfizer enter research collaboration

May 9, 2018

Alnylam achieves delivery of siRNA conjugates to CNS

May 9, 2018

Promising phase II results for TOP-1630 in dry eye syndrome

May 9, 2018

Celgene presents highlights of first quarter 2018

May 9, 2018

Biohaven establishes expanded access program for sublingual BHV-0223 for ALS

May 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....